429 related articles for article (PubMed ID: 20075417)
1. Changes in the expression profile of the meiosis-involved mismatch repair genes in impaired human spermatogenesis.
Terribas E; Bonache S; García-Arévalo M; Sánchez J; Franco E; Bassas L; Larriba S
J Androl; 2010; 31(4):346-57. PubMed ID: 20075417
[TBL] [Abstract][Full Text] [Related]
2. An intact Pms2 ATPase domain is not essential for male fertility.
Fischer JM; Dudley S; Miller AJ; Liskay RM
DNA Repair (Amst); 2016 Mar; 39():46-51. PubMed ID: 26753533
[TBL] [Abstract][Full Text] [Related]
3. Meiotic arrest and aneuploidy in MLH3-deficient mice.
Lipkin SM; Moens PB; Wang V; Lenzi M; Shanmugarajah D; Gilgeous A; Thomas J; Cheng J; Touchman JW; Green ED; Schwartzberg P; Collins FS; Cohen PE
Nat Genet; 2002 Aug; 31(4):385-90. PubMed ID: 12091911
[TBL] [Abstract][Full Text] [Related]
4. [Homologs of MutS and MutL during mammalian meiosis].
Santucci-Darmanin S; Paquis-Flucklinger V
Med Sci (Paris); 2003 Jan; 19(1):85-91. PubMed ID: 12836196
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of MLH3, MLH1, and MSH4 in maturation arrest.
Ferrás C; Fernandes S; Silva J; Barros A; Sousa M
Reprod Sci; 2012 Jun; 19(6):587-96. PubMed ID: 22344730
[TBL] [Abstract][Full Text] [Related]
6. Localization of MMR proteins on meiotic chromosomes in mice indicates distinct functions during prophase I.
Kolas NK; Svetlanov A; Lenzi ML; Macaluso FP; Lipkin SM; Liskay RM; Greally J; Edelmann W; Cohen PE
J Cell Biol; 2005 Nov; 171(3):447-58. PubMed ID: 16260499
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
[TBL] [Abstract][Full Text] [Related]
8. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
9. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
Leong V; Lorenowicz J; Kozij N; Guarné A
Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of meiotic progression in female mice bearing mutations in genes of the DNA mismatch repair pathway.
Kan R; Sun X; Kolas NK; Avdievich E; Kneitz B; Edelmann W; Cohen PE
Biol Reprod; 2008 Mar; 78(3):462-71. PubMed ID: 18057311
[TBL] [Abstract][Full Text] [Related]
11. DNA mismatch repair and colon cancer.
Marra G; Jiricny J
Adv Exp Med Biol; 2005; 570():85-123. PubMed ID: 18727499
[No Abstract] [Full Text] [Related]
12. Altered gene expression signature of early stages of the germ line supports the pre-meiotic origin of human spermatogenic failure.
Bonache S; Algaba F; Franco E; Bassas L; Larriba S
Andrology; 2014 Jul; 2(4):596-606. PubMed ID: 24803180
[TBL] [Abstract][Full Text] [Related]
13. Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements.
Chen J; Sadowski I
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4813-8. PubMed ID: 15781865
[TBL] [Abstract][Full Text] [Related]
14. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract][Full Text] [Related]
16. The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.
Borie C; Colas C; Dartigues P; Lazure T; Rince P; Buhard O; Folliot P; Chalastanis A; Muleris M; Hamelin R; Mercier D; Oliveira C; Seruca R; Chadburn A; Leblond V; Barete S; Gaïdano G; Martin A; Gaulard P; Fléjou JF; Raphael M; Duval A
Int J Cancer; 2009 Nov; 125(10):2360-6. PubMed ID: 19551857
[TBL] [Abstract][Full Text] [Related]
17. Mismatch repair and treatment resistance in ovarian cancer.
Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM
BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of human mismatch repair genes in adult T-cell leukemia.
Morimoto H; Tsukada J; Kominato Y; Tanaka Y
Am J Hematol; 2005 Feb; 78(2):100-7. PubMed ID: 15682421
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.
Cannavo E; Gerrits B; Marra G; Schlapbach R; Jiricny J
J Biol Chem; 2007 Feb; 282(5):2976-86. PubMed ID: 17148452
[TBL] [Abstract][Full Text] [Related]
20. Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.
Vogelsang M; Comino A; Zupanec N; Hudler P; Komel R
BMC Cancer; 2009 Oct; 9():382. PubMed ID: 19863800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]